Skip to main content

enGene Therapeutics Inc.

ENGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001980845

In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.

Other share classesENGNW

13F holders, Q2 2026

Institutional positions in enGene Therapeutics Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
60
−1 vs. Q1 2026
Shares held
50.0M
−6.14M (−10.9%) vs. Q1 2026
Total value
$86.5M
−$295.8M (−77.4%) vs. Q1 2026
New holders
21
15 more added
Sold out
22
16 more reduced

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 60 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 11 institutionsQ1 2024: 31 institutionsQ2 2024: 30 institutionsQ3 2024: 30 institutionsQ4 2024: 34 institutionsQ1 2025: 31 institutionsQ2 2025: 36 institutionsQ3 2025: 37 institutionsQ4 2025: 58 institutionsQ1 2026: 62 institutionsQ2 2026: 60 institutions
Value heldQ2 2026: $86.5M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $130.9MQ1 2024: $536.1MQ2 2024: $307.1MQ3 2024: $227.7MQ4 2024: $274.7MQ1 2025: $183.4MQ2 2025: $147.1MQ3 2025: $279.1MQ4 2025: $530.8MQ1 2026: $383.0MQ2 2026: $86.5M
Institutions holding ENGN and their total value by quarter
QuarterHoldersValue
Q2 202660$86.5M
Q1 202662$383.0M
Q4 202558$530.8M
Q3 202537$279.1M
Q2 202536$147.1M
Q1 202531$183.4M
Q4 202434$274.7M
Q3 202430$227.7M
Q2 202430$307.1M
Q1 202431$536.1M
Q4 202311$130.9M
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q1 2026.

Institutions holding ENGN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
SBI Securities Co., Ltd.28$480.00%00.0%Unchanged
Aquatic Capital Management LLC29$500.00%−1,350−97.9%Reduced
Farther Finance Advisors, LLC100$1730.00%+100New
Simplex Trading, LLC399$6900.00%+399New
Wolverine Asset Management LLC2,964$5.13K0.00%+2,964New
Wells Fargo & Company6,840$11.8K0.00%−5,627−45.1%Reduced
PFS Partners, LLC11,000$19.0K0.01%00.0%Unchanged
Royal Bank of Canada11,325$20.0K0.00%+780+7.4%Added
Virtu Financial LLC13,986$24.0K0.00%+13,986New
Point72 Asset Management, L.P.13,992$24.2K0.00%−159,399−91.9%Reduced
Fountainhead AM, LLC15,000$25.9K0.02%+15,000New
HRT Financial LP16,831$29.0K0.00%−15,186−47.4%Reduced
SEI Investments Co18,504$32.0K0.00%−41,532−69.2%Reduced
Raymond James Financial Inc21,356$36.9K0.00%+357+1.7%Added
Sectoral Asset Management Inc21,700$37.5K0.03%+21,700New
Susquehanna International Group, LLP24,470$42.3K0.00%+24,470New
BNP Paribas Arbitrage, SA25,419$44.0K0.00%−39,882−61.1%Reduced
Engineers Gate Manager LP27,286$47.2K0.00%+27,286New
Morgan Stanley33,086$57.2K0.00%−53,514−61.8%Reduced
Gsa Capital Partners LLP37,346$65.0K0.00%+37,346New
Dimensional Fund Advisors LP38,291$66.2K0.00%+1,418+3.8%Added
Verdad Advisers, LP39,300$68.0K0.07%+39,300New
Scientech Research LLC40,710$70.4K0.06%+40,710New
Jain Global LLC43,231$74.8K0.00%+43,231New
DAFNA Capital Management LLC74,650$129.1K0.02%−112,703−60.2%Reduced
Persistent Asset Partners Ltd114,493$198.1K0.06%+114,493New
Marquette Asset Management, LLC150,546$260.4K0.03%+150,546New
XTX Topco Ltd151,424$262.0K0.00%+57,928+62.0%Added
Two Sigma Investments, LP164,570$284.7K0.00%+5,501+3.5%Added
Privium Fund Management B.V.170,000$294.1K0.05%−182,087−51.7%Reduced
Qube Research & Technologies Ltd200,187$346.3K0.00%+200,187New
Elmind Capital, LP210,000$363.3K0.09%00.0%Unchanged
Squarepoint Ops LLC215,381$372.6K0.00%+166,482+340.5%Added
Woodline Partners LP250,000$432.5K0.00%00.0%Unchanged
Kennedy Capital Management, Inc.268,735$464.9K0.01%−157,046−36.9%Reduced
Barclays PLC282,515$488.8K0.00%+282,173+82,506.7%Added
Rangeley Capital, LLC305,102$527.8K0.52%+305,102New
Jane Street Group, LLC382,459$661.7K0.00%+226,458+145.2%Added
Seven Fleet Capital Management LP411,065$711.1K0.12%+411,065New
Kynam Capital Management, LP457,855$792.1K0.04%−898,988−66.3%Reduced
Eversept Partners, LP469,584$812.4K0.04%−40,959−8.0%Reduced
Quadrature Capital Ltd478,070$827.1K0.01%+444,273+1,314.5%Added
UBS Group AG509,087$880.7K0.00%+496,070+3,810.9%Added
Affinity Asset Advisors, LLC600,000$1.04M0.05%−10,370−1.7%Reduced
Citadel Advisors LLC717,686$1.24M0.00%+563,744+366.2%Added
Sr One Capital Management, LP747,750$1.29M0.12%00.0%Unchanged
Renaissance Technologies LLC829,700$1.44M0.00%+673,600+431.5%Added
Omega Fund Management, LLC876,357$1.52M0.82%00.0%Unchanged
Millennium Management LLC966,627$1.67M0.00%+6,946+0.7%Added
Balyasny Asset Management LLC1,007,344$1.74M0.00%−141,653−12.3%Reduced
Peapod Lane Capital LLC1,102,149$1.91M1.29%+1,102,149New
Acorn Capital Advisors, LLC1,271,257$2.20M0.60%+1,271,257New
Vestal Point Capital, LP1,667,430$2.88M0.07%−497,570−23.0%Reduced
ADAR1 Capital Management, LLC2,104,986$3.64M0.17%+1,971,300+1,474.6%Added
Nextech Invest, Ltd.2,324,943$4.02M0.19%00.0%Unchanged
Ameriprise Financial Inc2,675,876$4.63M0.00%+2,675,876New
Perceptive Advisors LLC4,822,169$8.34M0.13%−1,005,337−17.3%Reduced
Siren, L.L.C.6,256,662$10.8M0.22%+1,003,503+19.1%Added
BML Capital Management, LLC6,669,908$11.5M6.59%+6,669,908New
FCPM III Services B.V.9,632,561$16.7M2.22%00.0%Unchanged
VR Adviser, LLC0$00.00%−4,771,414−100.0%Sold out
Blue Owl Capital Holdings LP0$00.00%−4,416,353−100.0%Sold out
Deep Track Capital, LP0$00.00%−4,377,572−100.0%Sold out
Braidwell LP0$00.00%−2,456,870−100.0%Sold out
MPM Oncology Impact Management LP0$00.00%−1,845,373−100.0%Sold out
Franklin Resources Inc0$00.00%−1,314,993−100.0%Sold out
Polar Capital Holdings Plc0$00.00%−1,224,071−100.0%Sold out
Marshall Wace, LLP0$00.00%−343,928−100.0%Sold out
Monashee Investment Management LLC0$00.00%−320,000−100.0%Sold out
Birchview Capital, LP0$00.00%−250,000−100.0%Sold out
FMR LLC0$00.00%−232,200−100.0%Sold out
Trexquant Investment LP0$00.00%−104,697−100.0%Sold out
Geode Capital Management, LLC0$00.00%−38,802−100.0%Sold out
American Century Companies Inc0$00.00%−32,861−100.0%Sold out
Northern Trust Corp0$00.00%−30,085−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−26,613−100.0%Sold out
Pale Fire Capital SE0$00.00%−24,004−100.0%Sold out
Jump Financial, LLC0$00.00%−21,633−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−13,962−100.0%Sold out
JPMorgan Chase & Co0$00.00%−1,977−100.0%Sold out
Caitong International Asset Management Co., Ltd0$00.00%−163−100.0%Sold out
Citigroup Inc0$00.00%−99−100.0%Sold out
Deeter Investments LLP––––Not filed